Page last updated: 2024-08-16

mitomycin and dasatinib

mitomycin has been researched along with dasatinib in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Ambriović-Ristov, A; Bosnar, MH; Brozovic, A; Fritz, G; Majhen, D; Osmak, M; Stojanović, N	1
Gabig, TG; Romanov, V; Waltzer, WC; Whyard, T	1

Reviews

1 review(s) available for mitomycin and dasatinib

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

2 other study(ies) available for mitomycin and dasatinib

Article	Year
Integrin αvβ3 expression in tongue squamous carcinoma cells Cal27 confers anticancer drug resistance through loss of pSrc(Y418). Biochimica et biophysica acta, 2016, Volume: 1863, Issue:8 Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cisplatin; Dasatinib; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, src; Humans; Integrin alphaVbeta3; Integrin beta Chains; Mitomycin; Neoplasm Invasiveness; Neoplasm Proteins; Point Mutation; Protein Multimerization; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins pp60(c-src); RNA Interference; Tongue Neoplasms	2016
Clostridium perfringens enterotoxin as a potential drug for intravesical treatment of bladder cancer. Biochemical and biophysical research communications, 2016, 09-16, Volume: 478, Issue:2 Topics: Administration, Intravesical; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Claudin-4; Clostridium perfringens; Dasatinib; Drug Evaluation, Preclinical; Enterotoxins; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Mitomycin; Models, Biological; Molecular Targeted Therapy; Protein Binding; Receptor, EphA2; Recombinant Proteins; Spheroids, Cellular; src-Family Kinases; Urinary Bladder Neoplasms; Urothelium	2016

Article

Year

Integrin αvβ3 expression in tongue squamous carcinoma cells Cal27 confers anticancer drug resistance through loss of pSrc(Y418).

Biochimica et biophysica acta, 2016, Volume: 1863, Issue:8

Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cisplatin; Dasatinib; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, src; Humans; Integrin alphaVbeta3; Integrin beta Chains; Mitomycin; Neoplasm Invasiveness; Neoplasm Proteins; Point Mutation; Protein Multimerization; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins pp60(c-src); RNA Interference; Tongue Neoplasms

2016

Clostridium perfringens enterotoxin as a potential drug for intravesical treatment of bladder cancer.

Biochemical and biophysical research communications, 2016, 09-16, Volume: 478, Issue:2

Topics: Administration, Intravesical; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Claudin-4; Clostridium perfringens; Dasatinib; Drug Evaluation, Preclinical; Enterotoxins; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Mitomycin; Models, Biological; Molecular Targeted Therapy; Protein Binding; Receptor, EphA2; Recombinant Proteins; Spheroids, Cellular; src-Family Kinases; Urinary Bladder Neoplasms; Urothelium

2016